Forbion exceeds Growth Opportunities II target with EUR 470m first close

Dutch biopharma investor Forbion has held the first close for Forbion Growth Opportunities II at EUR 470m; the fund will invest in late-stage biopharma companies at a time when they need private capital, the GP told Unquote.